Profile data is unavailable for this security.
About the company
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
- Revenue in USD (TTM)681.50m
- Net income in USD21.70m
- Incorporated2014
- Employees3.77k
- LocationAvanos Medical Inc5405 Windward Parkway, Suite 100 SouthALPHARETTA 30004United StatesUSA
- Phone+1 (678) 425-9273
- Fax+1 (302) 636-5454
- Websitehttps://avanos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simulations Plus Inc | 70.01m | 9.95m | 640.75m | 243.00 | 65.24 | 3.51 | 41.02 | 9.15 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
| SI-Bone Inc | 150.71m | -40.85m | 651.68m | 344.00 | -- | 3.94 | -- | 4.32 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Iradimed Corp | 71.31m | 18.63m | 721.75m | 148.00 | 39.00 | 8.65 | 37.10 | 10.12 | 1.46 | 1.46 | 5.59 | 6.59 | 0.7851 | 1.42 | 6.16 | 481,791.50 | 20.51 | 13.16 | 22.48 | 14.58 | 77.14 | 76.55 | 26.12 | 21.46 | 7.82 | 143.27 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Orthofix Medical Inc | 784.25m | -119.03m | 735.62m | 1.63k | -- | 1.40 | -- | 0.938 | -3.14 | -3.14 | 20.72 | 13.76 | 0.8844 | 1.17 | 6.56 | 479,956.60 | -13.42 | -8.88 | -16.31 | -10.96 | 68.05 | 72.37 | -15.18 | -9.28 | 1.11 | -3.12 | 0.2069 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Standard Biotools Inc | 155.90m | -170.60m | 763.13m | 534.00 | -- | 1.56 | -- | 4.89 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Figs Inc | 548.65m | 10.84m | 804.75m | 354.00 | 79.82 | 1.98 | 48.59 | 1.47 | 0.059 | 0.059 | 3.08 | 2.38 | 1.11 | 1.33 | 65.26 | 1,549,845.00 | 2.20 | -- | 2.64 | -- | 67.67 | -- | 1.97 | -- | 3.28 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Embecta Corp | 1.12bn | 69.70m | 898.42m | 2.20k | 12.91 | -- | 8.30 | 0.803 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Avanos Medical Inc | 681.50m | 21.70m | 914.54m | 3.77k | 42.53 | 0.7437 | 13.53 | 1.34 | 0.4679 | 0.3385 | 14.70 | 26.76 | 0.4031 | 1.90 | 5.16 | 180,721.30 | 1.28 | -0.6527 | 1.45 | -0.7338 | 55.51 | 54.45 | 3.18 | -1.60 | 1.46 | 9.84 | 0.1164 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Castle Biosciences Inc | 311.88m | 6.08m | 918.08m | 610.00 | 163.97 | 2.08 | 47.01 | 2.94 | 0.1999 | 0.1999 | 11.07 | 15.77 | 0.6562 | 9.15 | 7.15 | 511,275.40 | 1.28 | -9.43 | 1.40 | -10.17 | 81.90 | 80.58 | 1.95 | -28.46 | 7.64 | -- | 0.0228 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
| Cytek Biosciences Inc | 201.21m | -10.16m | 925.80m | 645.00 | -- | 2.37 | -- | 4.60 | -0.0782 | -0.0782 | 1.52 | 2.97 | 0.3982 | 1.60 | 3.72 | 297,647.90 | -2.01 | -- | -2.29 | -- | 54.92 | -- | -5.05 | -- | 5.47 | -- | 0.0083 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Bioventus Inc | 555.06m | -39.48m | 960.87m | 1.03k | -- | 6.46 | -- | 1.73 | -0.6172 | -0.6172 | 8.68 | 1.83 | 0.7023 | 1.95 | 4.73 | 572,227.80 | -6.47 | -5.52 | -9.13 | -7.27 | 67.00 | 68.25 | -9.22 | -10.94 | 0.9866 | 1.13 | 0.6725 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
| Owens & Minor, Inc. | 10.66bn | -48.79m | 997.02m | 13.70k | -- | 1.14 | 4.50 | 0.0935 | -0.6346 | -0.6346 | 139.27 | 11.35 | 2.09 | 7.26 | 15.86 | 778,172.30 | -0.9561 | 1.32 | -1.49 | 2.07 | 20.72 | 16.48 | -0.4576 | 0.5614 | 0.4519 | 2.03 | 0.6831 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| CeriBell Inc | -100.00bn | -100.00bn | 1.03bn | -- | -- | -- | -- | -- | -- | -- | -- | 0.5919 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.53 | -- | 0.4912 | -- | 74.47 | -- | 20.72 | -- | -- | -- |
| Pulse Biosciences Inc | 0.00 | -46.13m | 1.09bn | 56.00 | -- | 13.79 | -- | -- | -0.8069 | -0.8069 | 0.00 | 1.29 | 0.00 | -- | -- | 0.00 | -58.03 | -93.21 | -62.84 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Artivion Inc | 376.97m | -8.32m | 1.16bn | 1.50k | -- | 3.93 | 77.39 | 3.08 | -0.2076 | -0.2076 | 9.11 | 7.06 | 0.481 | 1.67 | 5.44 | 251,316.00 | -1.07 | -2.20 | -1.15 | -2.36 | 64.63 | 65.51 | -2.22 | -5.34 | 4.04 | 1.07 | 0.5177 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Establishment Labs Holdings Inc | 151.35m | -83.20m | 1.18bn | 857.00 | -- | 26.30 | -- | 7.82 | -3.11 | -3.11 | 5.62 | 1.61 | 0.5307 | 0.8525 | 2.72 | 166,685.00 | -29.17 | -33.22 | -34.29 | -41.12 | 66.04 | 64.73 | -54.97 | -43.19 | 2.91 | -20.68 | 0.8114 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
Data as of Nov 13 2024. Currency figures normalised to Avanos Medical Inc's reporting currency: US Dollar USD
60.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2024 | 6.52m | 14.20% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 5.19m | 11.29% |
| RGM Capital LLCas of 30 Jun 2024 | 3.17m | 6.90% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 2.46m | 5.35% |
| T. Rowe Price Investment Management, Inc.as of 30 Jun 2024 | 2.22m | 4.83% |
| Westwood Management Corp. (Texas)as of 30 Jun 2024 | 2.08m | 4.54% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 1.82m | 3.97% |
| Brown Advisory LLCas of 30 Jun 2024 | 1.67m | 3.63% |
| William Blair Investment Management LLCas of 30 Sep 2024 | 1.38m | 3.00% |
| Paradice Investment Management LLCas of 30 Sep 2024 | 1.26m | 2.75% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
